Catherine Sorlet

Catherine Sorlet has been working in the field of molecular pharmacology for over 10 years. Catherine began their career as a research associate at Euroscreen, where they worked on developing assays for GPCRs. Catherine then moved to Ogeda SA, where they oversaw the development of recombinant cell lines and in vitro assays for various pharmacological targets. In their current role as head of molecular pharmacology at Epic Therapeutics, they are responsible for the development of new drugs and therapies.

Catherine Sorlet is a licenciée en sciences, with a focus in biochimie, from the University of Liège.

Catherine Sorlet works with Steven Ramael - Medical Director, François Fuks - Chief Scientific Advisor, and Vincent Lannoy - Intellectual Property & Legal Director. Catherine Sorlet reports to Franz Obermayr, CEO.